scholarly article | Q13442814 |
P50 | author | Steve Innes | Q55538042 |
Barbara Laughton | Q61160991 | ||
P2093 | author name string | Mark Cotton | |
Savvas Andronikou | |||
Martin Kidd | |||
Ronald van Toorn | |||
Els Dobbels | |||
Christelle Ackermann | |||
P2860 | cites work | Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course | Q73715294 |
Image evaluation of HIV encephalopathy: a multimodal approach using quantitative MR techniques | Q84127254 | ||
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era | Q24632654 | ||
Pediatric HIV — A Neglected Disease? | Q29013261 | ||
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
Neurological and developmental effects of HIV and AIDS in children and adolescents | Q30660506 | ||
CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation | Q30990125 | ||
Central nervous system abnormalities in pediatric human immunodeficiency virus infection | Q33857352 | ||
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial | Q33926151 | ||
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants | Q34175450 | ||
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals | Q34732904 | ||
Longitudinal developmental profile of children from low socio-economic circumstances in Cape Town, using the 1996 Griffiths Mental Development Scales | Q36227731 | ||
Pediatric HIV infection: neurologic and neuropsychologic findings | Q36713663 | ||
Neuropathology of early HIV-1 infection | Q36826608 | ||
Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study | Q36876216 | ||
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. | Q38495248 | ||
Central Nervous System Involvement of Children with Hiv Nfection | Q41930800 | ||
Invited article: an MRI-based approach to the diagnosis of white matter disorders | Q41964061 | ||
Neuroimaging and neuropathologic findings in AIDS patient with cytomegalovirus infection. | Q42496519 | ||
Neuroradiological findings in perinatally HIV-infected children | Q44260314 | ||
Neuroimaging findings in children perinatally infected with the human immunodeficiency virus | Q45753955 | ||
Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa | Q46965720 | ||
Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. | Q48396856 | ||
Terminal zones of myelination: MR evaluation of children aged 20-40 months | Q48449066 | ||
Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS. | Q48602952 | ||
Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. | Q50474016 | ||
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. | Q51803108 | ||
Use of the 1996 Griffiths Mental Development Scales for infants: a pilot study with a Black, South African sample. | Q51898888 | ||
The construct validity of the Griffiths Scales of Mental Development. | Q51971047 | ||
Sub-cortical white-grey matter contrast on MRI as a quantitative marker of diffuse HIV-related parenchymal abnormality. | Q52888106 | ||
Progressive multifocal leukoencephalopathy in an HIV-infected child | Q73101549 | ||
P433 | issue | 8 | |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | e207-12 | |
P577 | publication date | 2014-08-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy | |
P478 | volume | 33 |
Q93004858 | Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms |
Q46724981 | Altered brain morphometry in 7-year old HIV-infected children on early ART. |
Q36251762 | Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study |
Q37510621 | Early Antiretroviral Therapy in HIV-Infected Children Is Associated with Diffuse White Matter Structural Abnormality and Corpus Callosum Sparing |
Q34978945 | HIV Encephalopathy: pediatric case series description and insights from the clinic coalface |
Q35743630 | HIV-1 proteins, Tat and gp120, target the developing dopamine system |
Q37656252 | Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children |
Q59349495 | Human immunodeficiency virus-related cerebral white matter disease in children |
Q35599081 | Impact of earlier combination antiretroviral therapy on outcomes in children |
Q50042626 | Improved Neurodevelopment Following Antiretroviral Therapy in HIV-Infected Children |
Q60641763 | Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV |
Q47201399 | Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART. |
Q40443793 | Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity |
Q52774286 | Neurological Complications of HIV Infection. |
Q35984276 | Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? |
Q53800271 | Research gaps in neonatal HIV-related care. |
Q38841035 | The role of neuropsychology in UK pediatric HIV care: Relevance to clinical practice and research |
Search more.